Who
Wim Souverijns
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Pharvaris.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $2.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 May 2026
- Last trade
- 15 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $237K6,090 at $38.99 | filing |
| 15 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $237K6,090 at $38.99 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $349K20,000 at $17.43 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $786K20,000 at $39.31 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $349K20,000 at $17.43 | filing |
| 14 Sep 2026filed 16 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $786K20,000 at $39.31 | filing |
| 15 May 2026filed 19 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $299K10,000 at $29.92 | filing |
| 15 May 2026filed 19 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $299K10,000 at $29.92 | filing |
News
Wim Souverijns Sells 20,000 Shares of Pharvaris (NASDAQ:PHVS) Stockdailypolitical.com · 16 Sep 2026
1 headline in the last 90 days name Wim Souverijns; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.